Research progress on liver transplantation for benign liver tumors
10.3969/j.issn.1674-7445.2022.06.008
- VernacularTitle:良性肝脏肿瘤肝移植相关进展
- Author:
Yuanzhi NI
1
;
Wu ZHANG
Author Information
1. School of Medicine, Zhejiang University, Hangzhou 310000, China
- Publication Type:Research Article
- Keywords:
Benign liver tumor;
Liver transplantation;
Hepatic hemangioma;
Polycystic liver;
Hepatocellular adenoma;
Hepatic mesenchymal hamartoma;
Space-occupying compression;
Rupture bleeding
- From:
Organ Transplantation
2022;13(6):742-
- CountryChina
- Language:Chinese
-
Abstract:
Liver tumors can be divided into benign and malignant types. Benign liver tumors are relatively common, which are mainly treated with follow-up observation and interventional therapy, and surgical resection should be performed for few cases. Liver transplantation can effectively treat end-stage liver diseases, whereas it is seldom applied in the treatment of benign liver tumors. Liver transplantation is only considered for benign liver tumors with huge space-occupying compression, liver failure, the risk of tumor rupture and bleeding or malignant transformation. Compared with malignant tumors and chronic liver failure, liver transplantation yields an equivalent risk for benign liver tumors, favorable clinical prognosis and long-term survival. However, comprehensive evaluation should be delivered before liver transplantation for benign liver tumors, and extensive attention should be paid to the difficulty of donor liver matching in the new situation. In this article, research progress on liver transplantation for benign liver tumors including hepatic hemangioma, polycystic liver, hepatocellular adenoma, hepatic mesenchymal hamartoma was reviewed, aiming to provide reference for liver transplantation in the treatment of benign liver tumors.
